PIPA520821

RWDD3 Polyclonal Antibody, Invitrogen™

Manufacturer: Thermo Scientific

Select a Size

Pack Size SKU Availability Price
Each of 1 PIPA520821-Each-of-1 In Stock ₹ 46,591.50

PIPA520821 - Each of 1

₹ 46,591.50

In Stock

Quantity

1

Base Price: ₹ 46,591.50

GST (18%): ₹ 8,386.47

Total Price: ₹ 54,977.97

Antigen

RWDD3

Classification

Polyclonal

Conjugate

Unconjugated

Gene

RWDD3

Gene Alias

2510027J23Rik; 3110037C01Rik; AI035684; AI662458; pituitary tumor X2CR1 protein; RSUME; RWD domain containing 3; RWD domain-containing protein 3; RWD domain-containing sumoylation enhancer; RWD-containing sumoylation enhancer; Rwdd3; X2cr1

Host Species

Rabbit

Purification Method

Antigen affinity chromatography

Regulatory Status

RUO

Gene ID (Entrez)

25950, 65026, 66568

Content And Storage

Maintain refrigerated at 2-8°C for up to 3 months. For long term storage store at -20°C

Form

Liquid

Applications

Western Blot

Concentration

1 mg/mL

Formulation

PBS with 0.02% sodium azide

Gene Accession No.

P0C7N0, Q8VIL2, Q9Y3V2

Gene Symbols

RWDD3

Immunogen

A 17 amino acid peptide from near the amino terminus of human RWDD3.

Quantity

100 μg

Primary or Secondary

Primary

Target Species

Human, Mouse, Rat

Product Type

Antibody

Isotype

IgG

Related Products

Img

Thermo Scientific

PIPA520767

--

Img

Thermo Scientific

PIPA521173

--

Img

Thermo Scientific

PIPA520810

--

Img

Thermo Scientific

PIPA520853

--

Img

Thermo Scientific

PIPA520840

--

Img

Thermo Scientific

PIPA520918

--

Img

Thermo Scientific

PIPA520702

--

Img

Thermo Scientific

PIPA521083

--

Description

  • A suggested positive control is mouse kidney tissue lysate
  • PA5-20821 can be used with blocking peptide PEP-0935
  • RWDD3 (RSUME), a small RWD-containing protein, has a central role in sumoylation by enhancing SUMO conjugation in the regulatory network of immune-inflammatory signals
  • RWDD3 increases Ikappa-Beta sumoylation and stability
  • In addition, RWDD3 inhibits TNF-a-induced kappaB-LUC (Luciferase) reporter activity, showing the functional consequence of Ikappa-Beta increased stability
  • RSUME-enhanced sumoylation of Ikappa-Beta leads to the inhibition of NF-kappa-Beta activity on two well-known inflammatory genes, IL-8 and cyclooxygenase-2 (Cox-2) and therefore may also favor anti-inflammatory pathways
  • Expression of RWDD3 was induced under hypoxic conditions and it has a potential role during vascularization
  • Both BMP-4 and RWDD3 may be interesting targets for inhibiting steps involved in pituitary tumorigenesis.